Top Markets
Coin of the day
Arctic Bioscience AS Arctic Bioscience AS

Arctic Bioscience AS

ABS
Pozycja w akcjach #33046
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Cena akcji
$0.3144463
Kapitalizacja rynkowa
$8.48M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-2.55%
Kraj
NO
Handel Arctic Bioscience AS (ABS)

Kategoria

Historia stopy dywidendy dla Arctic Bioscience AS (ABS)
Stopa dywidendy (TTM) dla Arctic Bioscience AS (symbol akcji: ABS) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Arctic Bioscience AS (ABS) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji